Agios Pharmaceuticals, Inc. (LON:0HB0)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,185	1,497	977	1,280	1,318	2,198
Market Cap Growth	-19.28%	53.19%	-23.69%	-2.87%	-40.02%	-10.83%
Enterprise Value	279	219	352	504	360	1,937
Last Close Price	19.89	26.32	17.50	25.51	24.92	32.40
PE Ratio	-	2.78	-	-	1.11	-
PS Ratio	35.55	51.35	46.40	108.35	-	-
PB Ratio	1.24	1.22	1.54	1.40	1.38	7.51
P/TBV Ratio	1.24	1.22	1.54	1.40	1.38	7.51
EV/Sales Ratio	8.32	7.51	16.70	42.61	-	-
EV/FCF Ratio	-0.90	-	-	-	-	-
Debt / Equity Ratio	0.04	0.04	0.09	0.08	0.08	0.26
Asset Turnover	0.03	0.03	0.03	0.01	-	-
Inventory Turnover	11.63	13.08	21.65	-	-	-
Quick Ratio	12.81	11.06	11.49	12.54	17.17	6.07
Current Ratio	13.82	11.90	12.27	13.30	17.79	6.75
Return on Equity (ROE)	-27.57%	57.29%	-36.83%	-19.38%	-42.15%	-63.33%
Return on Assets (ROA)	-18.71%	-20.47%	-22.49%	-18.17%	-20.65%	-24.08%
Return on Invested Capital (ROIC)	-19.71%	-21.45%	-23.65%	-18.88%	-24.98%	-33.35%
Return on Capital Employed (ROCE)	-36.30%	-26.90%	-45.00%	-33.10%	-27.50%	-44.30%
Earnings Yield	-25.20%	35.95%	-28.29%	-15.02%	89.89%	-10.91%
FCF Yield	-26.00%	-20.89%	-23.87%	-20.38%	-23.14%	-10.16%
Buyback Yield / Dilution	-0.86%	-4.02%	-1.57%	9.36%	12.39%	-15.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.